Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 02:12PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.10 Insider Own6.35% Shs Outstand6.07M Perf Week14.56%
Market Cap29.14M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.69M Perf Month7.87%
Income-0.31M PEG- EPS next Q- Inst Own0.01% Short Float / Ratio0.24% / 1.23 Perf Quarter-18.23%
Sales0.00M P/S- EPS this Y- Inst Trans-5.52% Short Interest0.01M Perf Half Y-47.25%
Book/sh8.08 P/B0.59 EPS next Y- ROA-0.50% Target Price10.70 Perf Year-26.15%
Cash/sh6.82 P/C0.70 EPS next 5Y- ROE-1.22% 52W Range3.00 - 14.00 Perf YTD45.41%
Dividend- P/FCF- EPS past 5Y70.34% ROI-0.87% 52W High-65.71% Beta2.49
Dividend %- Quick Ratio3.65 Sales past 5Y0.00% Gross Margin- 52W Low60.00% ATR0.59
Employees49 Current Ratio3.65 Sales Q/Q- Oper. Margin0.00% RSI (14)51.90 Volatility15.63% 10.99%
OptionableNo Debt/Eq0.58 EPS Q/Q102.69% Profit Margin- Rel Volume0.58 Prev Close5.08
ShortableYes LT Debt/Eq0.43 Earnings- Payout- Avg Volume11.03K Price4.80
Recom1.00 SMA202.68% SMA501.86% SMA200-30.95% Volume4,695 Change-5.51%
Dec-06-23 04:05PM
Nov-14-23 04:05PM
Nov-07-23 12:00PM
Oct-24-23 04:05PM
Oct-23-23 04:05PM
12:00PM Loading…
Jun-28-23 04:05PM
Jun-27-23 12:00PM
Jun-26-23 04:05PM
Jun-23-23 04:30PM
Jun-20-23 04:05PM
Jun-14-23 02:00PM
Jun-13-23 12:00PM
Jun-12-23 01:00AM
Jun-05-23 02:00AM
04:05PM Loading…
May-24-23 04:05PM
May-23-23 04:05PM
May-16-23 12:00PM
May-15-23 04:45PM
May-12-23 12:00PM
May-09-23 02:00AM
Apr-17-23 04:05PM
Apr-12-23 12:00PM
Mar-22-23 05:05PM
Mar-06-23 12:00PM
Feb-15-23 04:30PM
Feb-09-23 12:00PM
Jan-09-23 12:00PM
Dec-06-22 12:00PM
Nov-21-22 04:05PM
04:05PM Loading…
Oct-13-22 04:05PM
Oct-05-22 12:00PM
Oct-04-22 12:00PM
Sep-12-22 04:05PM
Sep-06-22 04:30PM
Aug-26-22 01:21PM
Aug-25-22 06:35AM
Aug-24-22 04:05PM
Jul-07-22 12:00PM
Jun-24-22 04:05PM
Jun-03-22 12:00PM
May-24-22 04:05PM
May-17-22 04:05PM
May-13-22 12:00PM
May-12-22 04:05PM
Apr-28-22 04:05PM
Apr-25-22 02:00AM
Apr-06-22 04:05PM
Apr-04-22 01:30AM
Mar-28-22 04:05PM
Mar-11-22 05:18PM
Mar-04-22 12:00PM
Feb-09-22 12:53PM
Feb-08-22 04:05PM
Jan-10-22 12:00PM
Jan-03-22 04:05PM
Dec-14-21 01:30AM
Dec-13-21 04:05PM
Dec-10-21 12:00PM
Dec-01-21 09:22AM
Nov-29-21 04:05PM
Nov-15-21 04:05PM
Nov-10-21 01:30AM
Nov-09-21 02:00AM
Nov-05-21 01:21PM
Oct-25-21 12:11PM
Oct-07-21 12:00PM
Oct-04-21 04:05PM
Sep-28-21 04:05PM
Sep-22-21 12:30PM
Sep-20-21 04:05PM
Sep-15-21 04:05PM
Sep-06-21 04:05PM
Sep-03-21 12:00PM
Aug-30-21 04:05PM
Aug-24-21 04:30PM
Aug-05-21 12:00PM
Jul-30-21 08:50AM
Jul-29-21 04:05PM
Jul-27-21 01:30AM
Jul-21-21 04:05PM
Jul-06-21 12:00PM
Jun-25-21 04:30PM
Jun-07-21 12:00PM
May-26-21 04:30PM
May-25-21 04:00PM
May-07-21 12:00PM
May-04-21 04:30PM
Apr-29-21 02:30AM
Apr-28-21 07:30PM
Apr-20-21 01:30AM
Apr-19-21 01:30AM
Apr-07-21 04:30PM
Phaxiam Therapeutics SA is a biopharmaceutical company, which develops red blood cell-based therapeutics for severe forms of cancer and orphan diseases. It operates through the following technical platforms: ERYCAPS, ERYCEV and ERYTECH. The ERYCAPS which uses a novel technology to encapsulate drug substances inside red blood cells. The ERYCEV focuses on potential of drug-loaded extracellular vesicles, derived from red blood cells. ERYTECH developing product candidates for patients with unmet medical needs. The company was founded in 2004 and is headquartered in Lyon, France.